Keywords: Generics, Bipharma, Growth forecast, Malaysia, Frost & Sullivan

Generics and biopharma poised for growth in Asia, says Frost & Sullivan

Article | 21 June 2010

The global recession of 2009 left a deep impact on the health care industry in the USA and Europe. Asia Pacific ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in